FDA Approves Hypertriglyceridemia Drug That May Reduce Pancreatitis Risk
The US Food and Drug Administration (FDA) approved a new treatment for adults with severe hypertriglyceridemia, the first shown to reduce the risk of acute pancreatitis.
Original Source
Read the full article at Jamanetwork →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.